Pioglitazone, a Peroxisome Proliferator-Activated Receptor γ Agonist, Suppresses Rat Prostate Carcinogenesis

Pioglitazone (PGZ), a peroxisome proliferator-activated receptor γ agonist, which is known as a type 2 diabetes drug, inhibits cell proliferation in various cancer cell lines, including prostate carcinomas. This study focused on the effect of PGZ on prostate carcinogenesis using a transgenic rat for...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Shugo, Mori, Yukiko, Nagano, Aya, Naiki-Ito, Aya, Kato, Hiroyuki, Nagayasu, Yuko, Kobayashi, Mizuho, Kuno, Toshiya, Takahashi, Satoru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5187871/
https://www.ncbi.nlm.nih.gov/pubmed/27973395
http://dx.doi.org/10.3390/ijms17122071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5187871/
https://www.ncbi.nlm.nih.gov/pubmed/27973395
http://dx.doi.org/10.3390/ijms17122071

Ejemplares similares